ArticleCureus2026
Predictors of Recurrent Ureteral Stones: A Retrospective Analysis of Clinical, Demographic, and Metabolic Factors.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background While global meta-analyses have identified broad risk factors for kidney stone recurrence, data on specific determinants of recurrent ureteral stones in the Middle Eastern region remain limited. We aimed to identify the clinical, demographic, and metabolic determinants of recurrent ureteral stones, including body mass index (BMI). Materials This retrospective cohort study was conducted at a single institution in Saudi Arabia. Clinical data from 57 patients with ureteral stones were analyzed. The variables included age, sex, BMI, stone composition, comorbidities (diabetes mellitus (DM), hypertension (HT), and gout), and back pain. Univariate (independent t-tests and chi-square tests) and multivariate logistic regression models were used to assess associations with recurrence. Recurrence was defined as two or more episodes of stone passage or intervention within 12 months. Results Recurrence occurred in 30% of the patients. On multivariate analysis, gout (odds ratio (OR): 8.6, 95% confidence interval (CI): 1.3-56.7, p = 0.026) and uric acid stones (OR: 4.9, 95% CI: 1.1-21.9, p = 0.038) were independently associated with recurrence, while back pain showed a trend toward significance (OR: 4.1, 95% CI: 0.9-18.6, p = 0.07). BMI, age, and sex were not significantly associated (p > 0.05). Conclusion Gout and uric acid stone composition were independent predictors of ureteral stone recurrence. Despite the limitations of a small sample size and short follow-up period, targeted metabolic screening and management of hyperuricemia may reduce the risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.